Precision Medicine in Breast Medicine: A Real Change for Thousands of Women
Gianluca Franceschini, Director of the Integrated Center for Senology and the Breast Surgery Unit of the Gemelli Polyclinic, posted on LinkedIn:
”Precision medicine in Breast Medicine: a real change for thousands of women.
As Director of the Integrated Breast Center of the Gemelli Polyclinic, I see every day how scientific innovation can concretely transform the treatment path of our patients.
- Genomic tests, such as Oncotype DX, are rewriting the therapeutic approach to hormone-responsive breast cancers, which account for more than 70% of diagnoses.
- These tools help us understand who really benefits from chemotherapy and who can be safely treated with hormone therapy alone.
The result?
Thousands of women can avoid unnecessarily heavy treatments without reducing the effectiveness of treatment.
It is a decisive step forward in terms of quality of life, sustainability and personalization of treatment.
We continue to work – together with colleagues in Precision Medicine and National Research Groups – to further expand their use, even in the pre-operative phase, and to define increasingly personalized therapeutic strategies.
Precision medicine is not the future: it is already here. And it’s changing the lives of our patients, one treatment decision at a time.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Alessandra Fabi
Gianluca Franceschini ”
Read more here.
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 15:03Wolfgang Miesbach: The Most Underappreciated Challenges in Haemophilia Care Tackled at WFH 2026
-
Apr 20, 2026, 15:03Danielle Boyle: Patient Voices Transform Progress in ITP Research and Care with ISTH
-
Apr 20, 2026, 14:48Melissa Hollo: Intravenous Iron Shows Better Results Than Oral Iron in Pregnancy
-
Apr 20, 2026, 14:46Annalisa Paviglianiti: Real-World Outcomes of Maribavir for CMV After Hematopoietic Cell Transplantation
-
Apr 20, 2026, 14:45New Leadership and Expanding Global Impact in Hemophilia – WFH
-
Apr 20, 2026, 14:43Michael Baffuor-Asare: Rethinking How We Manage Rare Blood Groups
-
Apr 20, 2026, 14:42Noor Ahmed Mirwani: Infectious Mononucleosis Through the Lens of Atypical Lymphocytes
-
Apr 20, 2026, 14:40Irma Rastegayeva: The Evolution of Healthcare Access – From Royal Free Hospital to the Modern NHS
-
Apr 20, 2026, 14:37Brian O Mahony: With Old Friends From The Vietnam Haemophilia Association at WFH Congress 2026